Literature DB >> 17764785

Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial.

Fabienne Moritz1, Benoit Brousse, Bruno Gellée, Abdesslam Chajara, Erwan L'Her, Marie-France Hellot, Jacques Bénichou.   

Abstract

STUDY
OBJECTIVE: Patients with acute cardiogenic pulmonary edema may develop respiratory failure. Noninvasive respiratory support should be initiated rapidly to avoid tracheal intubation. The aim of this study is to compare the efficacy of continuous positive airway pressure (CPAP) delivered by the Boussignac CPAP device and bilevel positive airway pressure (bilevel PAP) in patients with acute respiratory failure caused by acute cardiogenic pulmonary edema.
METHODS: This prospective multicenter randomized study was conducted in 3 emergency departments. Patients were assigned to Boussignac CPAP through a facemask or to bilevel PAP, in addition to standard therapy. The main outcome was a combined criterion (tracheal intubation, death, or acute myocardial infarction). Complications, durations of ventilation, and hospitalization were also assessed.
RESULTS: After 1 hour of ventilation and at the end of the ventilation period, clinical parameters of respiratory distress and blood gas exchange significantly improved in each treatment arm. No significant differences were observed between the Boussignac CPAP and bilevel PAP arms for the combined criterion (5% versus 12%, respectively; odds ratio [OR] 0.4; 95% confidence interval [CI] 0.0 to 1.9) and also for severe complications (9% versus 6%; OR 1.5; 95% CI 0.3 to 9.9), duration of ventilation (median for both groups 2 hours; interquartile range [IQR] 1.2 to 3.0 hours), duration of hospitalization (CPAP 8.5 [IQR 6 to 14] days; bilevel PAP 10 [IQR 7 to 16] days), or intrahospital mortality (8% versus 14%; OR 1.8 [IQR 0.4 to 8.8]). Similar results were obtained among hypercapnic patients (PaCO2 >45 mm Hg). Whatever the ventilation support used, the combined criterion and severe complications were more frequently observed among hypercapnic patients.
CONCLUSION: Both Boussignac CPAP and bilevel PAP appeared effective in rapidly improving respiratory distress even in hypercapnic patients, but they were not different in terms of patient outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17764785     DOI: 10.1016/j.annemergmed.2007.06.488

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  19 in total

1.  Is the noninvasive ventilatory mode of importance during cardiogenic pulmonary edema?

Authors:  Erwan L'Her
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

2.  Non-invasive pressure support ventilation and CPAP in cardiogenic pulmonary edema: a multicenter randomized study in the emergency department.

Authors:  Semir Nouira; Riadh Boukef; Wahid Bouida; Wieme Kerkeni; Kaouther Beltaief; Hamdi Boubaker; Latifa Boudhib; Mohamed Habib Grissa; Mohamed Naceur Trimech; Hamadi Boussarsar; Mehdi Methamem; Soudani Marghli; Mondher Ltaief
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

3.  The use of the Boussignac CPAP device during cardiogenic pulmonary edema (CPE): why add air to the oxygen gas source?

Authors:  François Templier; Maidei Gugu Kabayadondo; Frédéric Thys
Journal:  Intensive Care Med       Date:  2011-06-21       Impact factor: 17.440

4.  Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting.

Authors:  Sean P Keenan; Tasnim Sinuff; Karen E A Burns; John Muscedere; Jim Kutsogiannis; Sangeeta Mehta; Deborah J Cook; Najib Ayas; Neill K J Adhikari; Lori Hand; Damon C Scales; Rose Pagnotta; Lynda Lazosky; Graeme Rocker; Sandra Dial; Kevin Laupland; Kevin Sanders; Peter Dodek
Journal:  CMAJ       Date:  2011-02-14       Impact factor: 8.262

5.  CPAP for acute cardiogenic pulmonary oedema from out-of-hospital to cardiac intensive care unit: a randomised multicentre study.

Authors:  Laurent Ducros; Damien Logeart; Eric Vicaut; Patrick Henry; Patrick Plaisance; Jean-Philippe Collet; Claire Broche; Papa Gueye; Muriel Vergne; David Goetgheber; Pierre-Yves Pennec; Vanessa Belpomme; Jean-Michel Tartière; Sophie Lagarde; Marius Placente; Marie-Laurence Fievet; Gilles Montalescot; Didier Payen
Journal:  Intensive Care Med       Date:  2011-07-30       Impact factor: 17.440

Review 6.  [Noninvasive ventilation in out-of-hospital emergency medicine].

Authors:  R Doppler
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-03-06       Impact factor: 0.840

7.  Mercury inhibition of avian fatty acid synthetase complex.

Authors:  W E Donaldson
Journal:  Chem Biol Interact       Date:  1975-11       Impact factor: 5.192

8.  [Non-invasive ventilation as treatment for acute respiratory insufficiency. Essentials from the new S3 guidelines].

Authors:  B Schönhofer; R Kuhlen; P Neumann; M Westhoff; C Berndt; H Sitter
Journal:  Anaesthesist       Date:  2008-11       Impact factor: 1.041

9.  Clinical practice guideline: non-invasive mechanical ventilation as treatment of acute respiratory failure.

Authors:  Bernd Schönhofer; Ralf Kuhlen; Peter Neumann; Michael Westhoff; Christian Berndt; Helmut Sitter
Journal:  Dtsch Arztebl Int       Date:  2008-06-13       Impact factor: 5.594

10.  Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: a pilot study.

Authors:  Rami N Khayat; William T Abraham; Brian Patt; Monica Roy; Keding Hua; David Jarjoura
Journal:  Chest       Date:  2008-07-18       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.